MarkZimmermanMD
Psychiatry • Cranston, RIProfessor, Psychiatry and Human Behavior, Brown University Program in Medicine
Dr. Zimmerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1170 Pontiac Ave
Cranston, RI 02920Phone+1 401-500-0424Fax+1 855-268-5333
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalResidency, Psychiatry, 1990 - 1994
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1990
Certifications & Licensure
RI State Medical License 1994 - 2026
PA State Medical License 1992 - 1994- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 37 citationsThe prevalence of atypical features across mood, anxiety, and personality disorders.Michael A. Posternak, Mark Zimmerman
Comprehensive Psychiatry. 2002-07-01 - 1347 citationsThe Hierarchical Taxonomy of Psychopathology (HiTOP): A Dimensional Alternative to Traditional NosologiesRoman Kotov, Robert F. Krueger, David Watson, Thomas M. Achenbach, Robert R. Althoff
Journal of Abnormal Psychology. 2017-03-23 - 5 citationsRe-examining borderline personality disorder and substance use disorder: The role of emotion dysregulationMiranda Bethanie Snow, Caroline Balling, Mark Zimmerman
Annals of Clinical Psychiatry. 2020-08-01
Journal Articles
- Validity of the DSM‐5 Anxious Distress Specifier for Major Depressive DisorderKristy Dalrymple, Mark Zimmerman, Depression and Anxiety
Other
- Using scales to monitor symptoms and treatment of depression (measurement based care)Zimmerman M
http://www.uptodate.com/contents/using-scales-to-monitor-symptoms-and-treatment-of-depression-measur
UpToDate, Wolters Kluwer Health - 2013-04-09
Press Mentions
Can Relmada’s Fast-Acting Pill for Major Depressive Disorder Compete in a Crowded Market?May 5th, 2022- Telehealth Safe, Effective for a Challenging Psychiatric DisorderNovember 11th, 2021
- Patient Satisfaction High for Psychiatric Telehealth Platforms in Partial Hospital ProgramMarch 25th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
